These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26388252)

  • 1. [Does the serum AMH assay allow predicting reliably female fertility?].
    Rolland AL; Dewailly D
    Gynecol Obstet Fertil; 2015 Oct; 43(10):670-5. PubMed ID: 26388252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMH as the primary marker for fertility.
    Dewailly D; Laven J
    Eur J Endocrinol; 2019 Dec; 181(6):D45-D51. PubMed ID: 31398713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness and indications of AMH assay in women].
    Fouquet A; Catteau-Jonard S; Peigné M; Pigny P; Dewailly D
    Ann Biol Clin (Paris); 2014; 72(6):681-8. PubMed ID: 25486664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of anti-Müllerian hormone in female fertility and infertility - an overview.
    Grynnerup AG; Lindhard A; Sørensen S
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1252-60. PubMed ID: 22646322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Level of AMH as a predictor of the result of ovarian stimulation].
    Vrublovský P
    Ceska Gynekol; 2016 Jan; 81(1):23-6. PubMed ID: 26982060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
    Moolhuijsen LME; Visser JA
    J Clin Endocrinol Metab; 2020 Nov; 105(11):3361-73. PubMed ID: 32770239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of clinical indicators, including serum anti-Müllerian hormone levels, for identification of women who should consider egg freezing.
    Martyn F; O'Brien YM; Wingfield M
    Int J Gynaecol Obstet; 2017 Jul; 138(1):37-41. PubMed ID: 28378324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mullerian hormone (AMH): what do we still need to know?
    La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
    Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
    Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMH: An ovarian reserve biomarker in assisted reproduction.
    Peluso C; Fonseca FL; Rodart IF; Cavalcanti V; Gastaldo G; Christofolini DM; Barbosa CP; Bianco B
    Clin Chim Acta; 2014 Nov; 437():175-82. PubMed ID: 25086280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti Müllerian Hormone: More than a biomarker of female reproductive function.
    Victoria M; Labrosse J; Krief F; Cédrin-Durnerin I; Comtet M; Grynberg M
    J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):19-24. PubMed ID: 30352309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimullerian hormone in cases of different reproductive pathologies.
    Barbakadze L; Kristasashvili J
    Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
    Broer SL; Broekmans FJ; Laven JS; Fauser BC
    Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of anti-Müllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.
    Safier LZ; Grossman LC; Chan CW; Sauer MV; Lobo RA; Douglas NC
    Int J Gynaecol Obstet; 2016 Oct; 135(1):73-6. PubMed ID: 27350232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment.
    Meczekalski B; Czyzyk A; Kunicki M; Podfigurna-Stopa A; Plociennik L; Jakiel G; Maciejewska-Jeske M; Lukaszuk K
    J Endocrinol Invest; 2016 Nov; 39(11):1259-1265. PubMed ID: 27300031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.